Memorial Sloan-Kettering Receives OK from NY State to Use Sequenom's MassArray | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Memorial Sloan-Kettering Cancer Center has received what it believes is the first approval from the New York State Department of Health to use Sequenom's MassArray Compact 384 system for diagnosing gene mutations in patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: weighting scheme increases GWAS power, and more.

Marc Tessier-Lavigne is to be the next president of Stanford University.

Walgreens has given Theranos 30 days to fix its lab issues, the Wall Street Journal reports.

Journals and research funding agencies pledge to enable the sharing of Zika virus research.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.